From Australia, new $173M research center strives to be at the forefront of pandemic drug discovery

In the battle against Covid-19, vaccines came much earlier than therapeutics. A new research institution in Melbourne wants to change that.

Geoffrey Cumming, a Canadian-born oil and gas businessman, donated AUD $250 million ($173.63 million) to establish the Cumming Global Centre for Pandemic Therapeutics — whose mandate is to fund “an ambitious research program focusing on treatments that can be rapidly adapted after a new virus is identified.”

It is among a growing group of initiatives, including one backed by the Gates Foundation and Novo Nordisk as well as grants from the NIH, to put an emphasis on antivirals as a crucial weapon for future pandemics — and to prepare for them.

Leaders said they hope to attract a host of researchers to the center who can work on molecular platforms and computational techniques to develop new drugs at top speed.

Duncan Maskell

“The…
Click here to view original post